AQR Capital Management - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 142 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.87 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2018$1,371,000
-48.3%
29,911
-33.3%
0.00%
-66.7%
Q2 2018$2,651,000
-11.2%
44,823
+2.2%
0.00%0.0%
Q1 2018$2,985,000
-33.2%
43,872
-3.0%
0.00%
-40.0%
Q4 2017$4,470,000
-22.7%
45,221
-6.3%
0.01%
-28.6%
Q3 2017$5,779,000
+263.2%
48,261
+165.1%
0.01%
+250.0%
Q2 2017$1,591,000
+298.7%
18,205
+35.8%
0.00%
+100.0%
Q2 2016$399,000
+37.1%
13,410
+35.5%
0.00%0.0%
Q1 2016$291,000
-61.2%
9,897
+3.5%
0.00%0.0%
Q4 2015$750,000
-53.2%
9,563
-55.0%
0.00%
-66.7%
Q3 2015$1,601,000
-47.3%
21,241
-18.4%
0.00%
-50.0%
Q2 2015$3,038,000
-23.2%
26,023
+55.4%
0.01%
-33.3%
Q1 2015$3,955,000
+16.4%
16,751
-6.7%
0.01%
+28.6%
Q4 2014$3,397,000
-6.9%
17,951
+17.4%
0.01%
-30.0%
Q3 2014$3,647,000
-47.7%
15,289
-85.5%
0.01%
-47.4%
Q2 2014$6,975,000
+79.1%
105,689
+182.7%
0.02%
+58.3%
Q1 2014$3,894,000
-40.5%
37,389
-40.8%
0.01%
-40.0%
Q4 2013$6,542,000
+97.2%
63,189
+2.2%
0.02%
+66.7%
Q3 2013$3,317,000
+920.6%
61,816
+745.1%
0.01%
+1100.0%
Q2 2013$325,000
-54.8%
7,315
-80.9%
0.00%
-66.7%
Q4 2012$719,00038,3270.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders